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RNA-binding proteins play crucial roles in directing
RNA translation to neuronal synapses. Staufen2
(Stau2) has been implicated in both dendritic RNA
localization and synaptic plasticity in mammalian
neurons. Here, we report the identification of func-
tionally relevant Stau2 target mRNAs in neurons.
The majority of Stau2-copurifying mRNAs expressed
in the hippocampus are present in neuronal pro-
cesses, further implicating Stau2 in dendritic mRNA
regulation. Stau2 targets are enriched for secondary
structures similar to those identified in the 30 UTRs of
Drosophila Staufen targets. Next, we show that
Stau2 regulates steady-state levels of many neuronal
RNAs and that its targets are predominantly downre-
gulated in Stau2-deficient neurons. Detailed analysis
confirms that Stau2 stabilizes the expression of one
synaptic signaling component, the regulator of G
protein signaling 4 (Rgs4) mRNA, via its 30 UTR.
This study defines the global impact of Stau2 on
mRNAs in neurons, revealing a role in stabilization
of the levels of synaptic targets.
INTRODUCTION
In neurons, RNA-binding proteins (RBPs) are essential for direct-
ing gene expression to distinct regions of the cell, such as growth
cones or synapses (Holt and Bullock, 2009). Local protein
synthesis in neuronal dendrites and at synapses is critically
important for both synaptic development and plasticity (Costa-
Mattioli et al., 2009; Sutton and Schuman, 2006; Kandel,
2009). Staufen proteins are double-stranded RBPs (dsRBP)Cell Reinvolved in RNA localization and synaptic plasticity (Dubnau
et al., 2003; Lebeau et al., 2011; St Johnston et al., 1991).
Work in several organisms indicates a role in RNA transport,
stability, translation, and anchoring (Dugre´-Brisson et al., 2005;
Kim et al., 2005; Micklem et al., 2000; Tang et al., 2001; Zimyanin
et al., 2008). However, Staufen’s role in RNA localization in
neurons is not well understood.
Staufen2 (Stau2) is highly enriched in the brain and is impor-
tant for dendritic spine morphogenesis, which represent excit-
atory synapses (Goetze et al., 2006). It is viewed as one of the
best markers to follow the transport of RNPs due to its fast bidi-
rectional movement along dendritic microtubules (Ko¨hrmann
et al., 1999; Zimyanin et al., 2008). Supporting its role in RNA
localization, expression of a dominant-negative Stau2 relocal-
izes a large proportion of total dendritic RNA toward the cell
body (Tang et al., 2001). Furthermore, downregulation of Stau2
in neurons impairs metabotropic glutamate receptor (mGluR)-
dependent long-term depression (LTD) (Lebeau et al., 2011).
Outstanding questions regarding the role of Stau2 in mature
neurons include which mRNAs it interacts with and whether it
plays a role in regulating their expression or localization. Here,
we sought to globally identify which mRNAs are associated
with Stau2 protein in the brain and investigate their regulation.
We report that Stau2 modulates the expression—most notably
the stabilization—of a subset of target RNAs that encode synap-
tic proteins. These targets are enriched for a recently identified
RNA secondary structure bound by Drosophila Staufen (Laver
et al., 2013). In conclusion, our data identify a mechanism for
Stau2 regulation of synaptic targets in neurons.
RESULTS
Identification of Stau2 Target RNAs from Rodent Brain
To isolate Stau2-containing RNA granules not linked to mem-
branes, we developed a protocol for RNP purification (Fritzscheports 5, 1511–1518, December 26, 2013 ª2013 The Authors 1511
Figure 1. Identification of Stau2 Target
RNAs from Soluble Stau2 RNPs
(A) The three-step biochemical procedure to
isolate endogenous Stau2 RNPs and identify their
RNA content.
(B) Heatmap of Affymetrix GeneChip arrays
showing the relative intensity of significantly en-
riched genes (adjusted p value < 0.05) in the Stau2
IP compared to the input from three independent
experiments. Each row represents a single mRNA.
(C) Validation of microarrays by qRT-PCR. mRNA
was isolated from input, Stau2 IPs, control IPs
(using rabbit preimmune sera), and the candidate
target genes quantified by qRT-PCR. Enrichment
was calculated as the IP relative to input and
cross-normalized to the reference genesKif5c and
Arntl. The mean ± SEM is shown (nR 3).
(D) Correlation of enrichment values (Stau2 IP/
input) obtained by microarray versus qRT-PCR.
Each point represents an individual mRNA, which
was quantified using both methods (n R 2).
Pearson’s correlation coefficient was significant
(p < 0.0001).
(E) Selected GO term enrichments observed for
Stau2-associated mRNAs. RNAs enriched R1.5-
fold (Stau2 IP/input) were used (n = 1,113).
See also Figure S1 and Tables S1 and S2.et al., 2013) (Figure 1A). Soluble (S20) embryonic day 17 (E17) rat
brain preparations were separated by density gradient centrifu-
gation. Western blotting was used to identify those fractions
that were enriched for Stau2 but depleted of endoplasmic retic-
ulum (ER). Fractionation before immunoprecipitation (IP) greatly
reduces nonspecific interactors, as the ER is associated with
ribosomes and translating RNAs.
Affinity-purifiedmonospecificStau2antibodiescoupled topro-
tein A beads were used to isolate endogenous RNPs from ER-
depleted brain fractions. In three independent experiments, total
RNA was isolated from the IP and analyzed by microarray. Equal
amounts of IP and input RNAwere hybridized to the array and the
identified RNAs were ranked by enrichment in the IP relative to
input (Table S1). This identified a total of 1,206 RNAs significantly
enriched in theStau2 IP (usinganaverageof >1.5-foldenrichment
as a cutoff across three IPs and an adjusted p value < 0.05;1512 Cell Reports 5, 1511–1518, December 26, 2013 ª2013 The AuthorsFigure 1B). This represents 8.5% of
mRNAs expressed in the input fractions.
The enrichment of 38 candidate RNAs
from independent IPs was confirmed by
quantitative RT-PCR (qRT-PCR) (Fig-
ure 1C; Table S2). The candidates in-
cluded RNAs with a range of enrichments
and abundance to ensure that all classes
of RNAs could be validated. Preimmune
serum coupled to protein A beads was
used as a negative control (Figure 1C).
Note that the preimmune IPs could not
be used as a control for the microarrays
because insufficient RNA was isolated.
The correlation between qRT-PCR and
microarray data for the selected 38 geneswas highly significant (Pearson’s correlation coefficient, p <
0.0001; Figure 1D), indicating that the microarray data are robust
and reliable. As an independent control, we testedwhether candi-
date RNAswere enriched in the IP of another RBP, Barentsz (Btz),
which forms distinct RNPs compared to Stau2 in neurons (Fritz-
sche et al., 2013). Only one (Sacm1l) out of the six tested Stau2
target RNAs was also enriched in the Btz IP (Figure S1A). Indeed,
no overlapping targets were enriched >2-fold in both IPs by
microarray analysis (M.A.K., M.D., J.E.H.-F., D. Karra, P.P., S.T.,
and M. B., unpublished data) further suggesting that most of the
identified Stau2 targets are specific to this RNP.
Increasing evidence demonstrates that individual RBPs can
regulate a biologically coherent set of target RNAs and coordi-
nate their expression (Hogan et al., 2008; Keene, 2007; Ule
et al., 2005). Therefore, we performed DAVID Gene Ontology
(GO) term analysis of the Stau2 targets (>1.5-fold) and identified
Figure 2. Most Stau2 Targets Localize to Neuronal Processes in the
Hippocampus CA1 Region
(A) Stau2 targets identified in this study were compared to a new data set of
process-localized mRNAs from the CA1 region of the hippocampus (Cajigas
et al., 2012). The data set was derived from RNA sequencing of the soma and
neuropil layers from the CA1 region of mouse hippocampus. The first column
indicates the number and percentage of Stau2 target RNAs expressed in the
CA1 somatic layer. The second column indicates the number and percentage
of Stau2 target mRNAs that are expressed in the CA1 that are also found in the
neuropil (77%).
(B) Localization of two Stau2 target mRNAs, Rgs4 and Calm3, was tested by
fluorescent in situ hybridization using digoxigenin-labeled riboprobes in pri-
mary hippocampal neurons (15–16 days in vitro). Sense probes were used as
negative controls. Scale bar, 10 mM.
See also Table S3.
Cell Reenriched classes of genes (Huang et al., 2009). We found a sig-
nificant enrichment of several GO term categories, including pro-
tein localization and signal transduction mediated by small
GTPases (p values of 5.43 1010 and 3.43 1010, respectively;
Figure 1E). Interestingly, eight RNAs encode proteins that are
part of a G protein-coupled receptor (GPCR) signaling pathway
(Figure S1B). This pathway is important for signaling through
synaptic receptors such as the dopamine, glutamate, and
muscarinic acetylcholine receptors, among others (Lin et al.,
2002; Miura et al., 2002; Rashid et al., 2007). This result raises
the possibility that Stau2 may regulate RNAs encoding function-
ally related proteins as described for other neuronal RBPs, such
as Nova and FMRP (Darnell et al., 2011; Ule et al., 2005). In sup-
port of a possible role of Stau2 in intracellular signaling
cascades, we found both ERK1 and ERK2 kinases to be misre-
gulated when Stau2 levels were reduced in primary cortical
neurons (Figures S1C and S1D).
The Majority of Stau2 Target mRNAs Are Localized
to Neuronal Processes
Local translation at synapses contributes to several forms of
synaptic plasticity (Costa-Mattioli et al., 2009; Sutton and Schu-
man, 2006). Recent data indicate that 2,550 mRNAs localize to
the processes of CA1 neurons in the hippocampus (Cajigas
et al., 2012). According to those data, 3,508 transcripts were ex-
pressed in these cells, therefore suggesting that 72% of all
RNAs in the CA1 processes may be locally translated. To deter-
mine the number of Stau2 target mRNAs in this local pool, we
cross-referenced our data set with that of Cajigas et al. (2012)
(Table S3). Approximately 30% of the Stau2 targets were ex-
pressed in the CA1 somatic layer (Figure 2A). Of these, 77%
were found in the neuropil layer, which consists of neuronal pro-
cesses (Figure 2A). This is a small but significant enrichment of
localized messages in the IP over input, which also consisted
of 72% localized messaged (resampling without replacement,
p = 0.012). This suggests that the majority of endogenous Stau2
target RNAs localize away from the cell body into neuronal pro-
cesses. Using fluorescence in situ hybridization (FISH), we
further confirmed the localization of two Stau2 targets of interest,
Rgs4 and Calm3, to dendrites of primary rat hippocampal
neurons (Figure 2B). Thus, Stau2 may play a role in dendritic
localization of its target mRNAs.
Stau2 Regulates mRNA Levels in Primary Neurons
To elucidate the role of Stau2 on the regulation of target mRNAs
in primary neurons, we investigated the impact of Stau2 downre-
gulation on global gene expression. Primary cortical neurons
were transduced with lentivirus vectors expressing short hairpin
RNAs (shRNAs), which target Stau2 or a control hairpin (targeting
luciferase). After 5 days, total RNA was isolated and differences
in gene expression were identified by microarray from three
independent experiments. When Stau2 levels were reduced to
10% of endogenous levels, 349 target mRNAs were downre-
gulated and 99 upregulated (Figure 3A, lane 3; Figure 3B; Table
S4). Interestingly, however, when a less potent shRNAwas used,
resulting in 30% of Stau2 remaining (shStau2-v3; Figure 3A, lane
4), the levels of only 13 RNAs changed (Figure S2A), with Stau2
itself being the only common target. These results suggest thatports 5, 1511–1518, December 26, 2013 ª2013 The Authors 1513
Figure 3. Stau2 Regulates mRNA Levels in
Primary Neurons
(A) Western blot from primary cortical neurons
transduced with lentivirus expressing two inde-
pendent shRNAs targeting Stau2 or controls (2 + 5
DIV). Four isoforms of Stau2 (62, 59, 56, and
52 kDa) are expressed. Tubulin was used as
loading control.
(B) Microarray analysis was performed on total
RNA isolated from shStau2-v2 and shControl-v2
transduced primary cortical neurons. Significantly
changedmRNAs are ordered by fold change in the
knockdown relative to the control. Each dot rep-
resents a single mRNA, with red showing down-
regulated mRNAs and green showing upregulated
mRNAs. Stau2 is indicated because it was the
most downregulated RNA.
(C) qRT-PCR validation of eight mRNAs from the
microarray. Relative levels of the indicated RNAs
were determined in the shStau2-v2 knockdown
relative to the control, shControl-v2, using cross-
normalization to the reference genes Kif5c and
PPIA. Bars represent the mean ± SEM (n = 3).
(D) Correlation between the validated targets
shown in (C) and the fold change for the same
targets according to the microarray (Pearson’s
correlation coefficient, p < 0.001).
(E and F) GO terms enrichments (p < 0.05) for
significantly downregulated (E) and upregulated
(F) mRNAs following Stau2 downregulation (KD)
in cortical neurons (shStau2-v2). Benjamini-
Hochberg (BH) adjusted p values are shown.
See also Figure S2 and Table S4.30% of normal Stau2 levels are sufficient to maintain target
mRNA levels in primary neurons. Themicroarray data were again
validated by qRT-PCR, showing a high correlation between both
data sets (Figures 3C, 3D, S2B, and S2C). Interestingly, the
downregulated RNAs were enriched for ‘‘synaptic’’ and
‘‘learning and memory’’-related GO term categories, whereas
the upregulated ones were enriched for different GO terms (Fig-
ures 3E and 3F). Together, gene expression analysis shows that
the majority of target genes identified are downregulated in
Stau2 knockdown neurons.
Identification of a Staufen-Recognized Structure in
Downregulated Stau2 Targets
In order to further investigate how Stau2 might regulate specific
transcripts in the brain, we searched for structural elements en-
riched in Stau2 targets. Here, we took advantage of our two
independentmicroarray experiments to select themost stringent
set of targets. Specifically, we selected those mRNAs that were
enriched in the IP of endogenous Stau2 RNPs from rat brain,
which were also affected by Stau2 downregulation in primary1514 Cell Reports 5, 1511–1518, December 26, 2013 ª2013 The Authorsneurons. This resulted in 32 targets
whose levels decreased in the absence
of Stau2 and 6 that increased (Figure 4A;
Table S5). Interestingly, and in line
with what was recently reported for
Drosophila Staufen targets (Laver et al.,2013), the median length of the 30 UTRs of Stau2-regulated
targets was significantly greater than that in the rat 30 UTRome
(1,189 bases for targets versus 496 bases for the rat 30 UTRome,
Wilcoxon rank sum p < 0.0001; Figure 4B). We next took advan-
tage of a novel computational strategy that was recently used to
identify structural elements in Drosophila Staufen target RNAs
(Laver et al., 2013) to assess whether the Stau2 targets were
enriched for Staufen-recognized structures (SRSs) similar to
those in Drosophila. We found that the Stau2 target 30 UTRs
were highly enriched for Type III SRSs (Wilcoxon rank sum p <
0.001; Figure 4C). Type III SRSs are defined by a stem consisting
of at least 10 out of 12 paired bases and no more than two
‘‘unpaired’’ bases (i.e., those that participate in neither canonical
nor noncanonical base pairings) (Laver et al., 2013). Notably,
95% (19 out of 20) of the analyzed downregulated targets carried
one or more Type III SRSs whereas only 33% (one out of three)
analyzed upregulated targets contained a type III SRSs (Fig-
ure S3; data not shown).
Given that downregulation was the predominant effect of
Stau2 knockdown on the target RNAs, we further validated
Figure 4. Stau2-Stabilized Target mRNA 30 UTRs Are Enriched for Staufen-Recognized Structures
(A) Overlap between mRNAs enriched in the Stau2 IP (from Figure 1) and mRNAs significantly changed following Stau2 knockdown (from Figure 3B). mRNAs
changed following the Stau2 knockdown (KD) are separated into upregulated (green circle) and downregulated (red circle).
(B) Median 30 UTR length of Stau2-regulated targets (overlap shown in A) compared to the rat genome. Note that only 23 of the 38 targets shown in (A) could be
used for this analysis due to incomplete database entries for the remainder (see Experimental Procedures). p < 0.0001, Wilcoxon rank sum test.
(C) Type III Staufen-recognized structures (SRSs) were mapped in the 30 UTRs of Stau2 targets and nontargets. The average number of Type III SRSs per
transcript and the frequency of SRSs are shown, both of which were significantly different between Stau2 targets (n = 20) and the rat 30 UTRome (n = 11,775).
Wilcoxon rank sum test p values are shown.
(legend continued on next page)
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one target, the regulator of G protein signaling 4 (Rgs4), which is
one of the synaptic mRNAs of the GPCR pathway and was
reduced by both Stau2 shRNAs to a statistically significant level
(reduced by 49% and 40% with shStau2-2 and shStau2-3,
respectively; Figure 4D). Note that shStau2-3 produces a stron-
ger knockdown when nucleofection or calcium transfection was
used, as compared to the viral-mediated knockdown shown
earlier (Figures S4A–S4C). The Rgs4 mRNA 30 UTR (ENSR-
NOG0000002773 in Figure S3A) contains two Type III SRSs.
This effect was further validated at the single-cell level using
Rgs4 FISH following Stau2 downregulation with shStau2-2 (Fig-
ure 4E) and shStau2-3 (data not shown), where the effect was
even more stark (Student’s t test p < 0.0001). Since there was
almost no Rgs4 left in the processes of Stau2-downregulated
neurons, only the cell body levels could be quantified.
To determine whether the observed reduction of Rgs4 mRNA
upon Stau2 knockdown is mediated via its 30 UTR, we generated
an Rgs4 30 UTR luciferase reporter and performed luciferase
assays in cortical neurons. Consistent with the reduction in
endogenous Rgs4 RNA we observed upon Stau2 knockdown,
Rgs4 reporter expression significantly decreased upon Stau2
downregulation with both shRNAs (Figure 4F). Together with
the qRT-PCR results, these findings suggest that Stau2 stabi-
lizes the Rgs4 mRNA via it’s 30 UTR.
CONCLUSIONS AND OUTLOOK
Here, we sought to identify physiologically relevant Stau2 targets
using a combined approach of immunoprecipitation of Stau2-
associated RNAs (to identify targets) together with the effect of
downregulation on those targets (to identify the role of Stau2 in
posttranscriptional regulation of these targets). While other
studies have identified candidate Stau2 targets, we found very
little overlap with our data set (Figure S4D), most likely because
the earlier studies did not fractionate Stau2-containing particles
away from ER. We believe that the more stringent approach
described here has yielded several insights into Stau2 function.
First, we have provided evidence for a role of Stau2 in the
stabilization of mRNAs as Stau2 targets were predominantly
downregulated in Stau2-deficient neurons. We note that the
levels of a small fraction of Stau2 targets increase upon Stau2
downregulation, consistent with a recent study in human cell
lines that implicates Stau2 in transcript destabilization (Park
et al., 2013). Although no such role of transcript stabilization
has been reported for Stau2 before, there is a recent publication(D) qRT-PCR of Stau2 and Rgs4 mRNAs following knockdown of Stau2 in cort
shStau2 samples were determined using the DDCT method and cross-normaliz
change ± SEM (n = 5). Significant differences were determined between shStau2
(E) Rgs4 FISH in primary hippocampal neurons following knockdown of Stau2. T
later for FISH. Antisense RNA probes were used to detect endogenous Rgs4mRN
indicated with an asterisk in the FISH image. Note that some bleed-through from t
underestimates differences in the quantification. Average cell body intensity o
neighboring untransfected cells. Bars represent the mean ratio of transfected
(shControl-2, n = 25; shStau2-2, n = 25). Scale bar, 10 mM.
(F) Dual luciferase reporter assay in cortical neurons. Renilla activity was normalize
to shControl-1 and the luciferase empty vector. Bars represent the mean relative lu
p values were calculated using the Student’s t test.
See also Figures S3 and S4 and Tables S5 and S6.
1516 Cell Reports 5, 1511–1518, December 26, 2013 ª2013 The Autfor Stau1, together with the long noncoding RNA TINCR,
showing a role in stabilizing differentiation mRNAs in human
keratinocytes (Kretz et al., 2013).
Second, our computational analysis of the Stau2 targets sug-
gests that it recognizes targets via secondary structures similar
to those that Drosophila Staufen recognizes in the 30 UTRs of
its targets (Laver et al., 2013). Given that the Rgs4 30-UTR con-
tains two such secondary structures (Type III SRSs) and together
with our finding that a reporter RNA carrying the Rgs4 30-UTR
behaves similarly to endogenous Rgs4 mRNA upon Stau2
knockdown, this supports the hypothesis that Stau2 regulates
its target RNAs by binding to type III SRSs in their 30 UTRs.
Thus, the secondary structures recognized by Staufen family
proteins may be conserved from flies to mammals.
Third, given that Rgs4 is a synaptic signaling molecule and
Stau2 downregulation has previously described synaptic pheno-
types (Goetze et al., 2006; Lebeau et al., 2011), misregulation of
Rgs4 following Stau2 knockdown could provide a mechanism
for the observed phenotypes. It is of particular note that Rgs4
has been linked to neuropsychiatric disorders (Terzi et al.,
2009), the stress response (Ni et al., 1999), and is responsive
to antidepressant drugs (Stratinaki et al., 2013). Therefore, regu-
lation by Stau2 would be of wide interest not only in the field of
RNA biology but also in clinical neurosciences.
Finally, it is very likely that mammalian Staufen proteins act as
multifunctional posttranscriptional regulators (St Johnston,
2005). In neurons, Stau2 likely plays a role in mRNA localization,
stability, and translation. Here, we focused on its effects on
mRNA regulation, uncovering a novel function in the stabilization
of steady-state levels of synaptic target RNAs, thus providing a
link between the molecular role of Stau2 as an RBP and its
cellular functions at the synapse.
EXPERIMENTAL PROCEDURES
Immunoprecipitations, RNA Isolation, and qRT-PCR
IPs were performed as described in RNase-free conditions on ice (Fritzsche
et al., 2013). RNA was isolated directly from beads and subjected to qRT-
PCR or microarray analysis in a minimum of three independent experiments.
Microarrays
For IP microarray analysis, RNA (200 ng) from input or IP was used for identi-
fying Stau2-associated RNAs. Preparation of terminal-labeled cDNA, hybridi-
zation to genome-wide GeneChip Rat Gene 1.0 ST Array (Affymetrix) and
scanning of the arrays were carried out according to manufacturer’s protocols
(https://www.affymetrix.com). Each IP as well as RNA isolated from the input
sample was analyzed from three biological replicates. Microarray data wereical neurons. Differences in steady-state RNA levels between shControl and
ation to the reference genes PPIA, Arntl, and Vinculin. Bars represent mean
and shControl samples using the Student’s t test. **p < 0.01, ***p < 0.001.
he 8 DIV neurons were transfected with the indicated shRNA and fixed 4 days
A and GFP antibodies to detect shRNA-transfected cells. Transfected cells are
he GFP staining leads to a diffuse signal in the FISH channel, which also slightly
f Rgs4 FISH signal was quantified from transfected cells and normalized to
to untransfected cells ± SEM taken from three independent experiments
d to Firefly to control for transfection efficiency. This ratio was then normalized
ciferase activity ±SEM (nR 4).Sepp1 is an unaffected Stau2-enrichedmRNA.
hors
analyzed with the R/BioConductor suite (http://www.bioconductor.org).
Robust multiarray analysis was used for normalization (Irizarry et al., 2003).
A linear model was used for inferring differential expression between groups
(Smyth, 2004). p values were adjusted using the Benjamini-Hochberg method
(Benjamini and Hochberg, 1995). For knockdown microarrays, the GeneChip
Rat Gene 2.0 ST Array (Affymetrix) was used. The experiment and analysis
were performed as described above.
FISH and Immunocytochemistry
FISH using tyramide signal amplification was performed as described previ-
ously (Vessey et al., 2008). The following RNA probes were used: Calm3 sense
and antisense from EST IMAGp998L0619945Q (accession number
AF231407), 1.3 kb from the 30 UTR of Calm3; Rgs4 (accession number
NM_017214) antisense probe in the first 1 kb of the 30 UTR, sense probe in
the last 1.3 kb of the 30 UTR. Immunocytochemistry was performed as previ-
ously described (Zeitelhofer et al., 2008). Images were acquired using an
Axioplan microscope (Zeiss) with a 633 planApo oil-immersion objective,
1.40 NA, and an F-view II charge-coupled device camera (Olympus). For
FISH following Stau2 knockdown, 8 days in vitro (DIV) primary hippocampal
neurons were transfected using calcium phosphate and fixed at 12 DIV.
Images were acquired using an Observer Z1 microscope (Zeiss) with a 633
planApo oil-immersion objective, 1.40 NA, and an CoolSnap HQ2 camera
(Olympus). Quantification of average cell body intensity was carried out using
Zen (Zeiss). An equal number of transfected and untransfected cells from each
coverslip (from three independent experiments) were quantified and the ratio
of transfected to untransfected used to determine differences between
shStau2 and shControl cells.
Antibodies
Monospecific Stau2 and Barentsz rabbit polyclonal antibodies were generated
in our laboratory by affinity purification from existing immune sera: Staufen2
antibodies were directed against the 62 kDa isoform of mouse Stau2
(Zeitelhofer et al., 2008), and anti-Btz antibodies were directed against the C
terminus of Btz (amino acids 356–527) (Macchi et al., 2003). The following
commercial antibodies were used: anti-phospho ERK1/2 (Cell Signaling
Technologies, 4370), anti-ERK1/2 (Cell Signaling Technologies, 4696),
anti-Tubulin (Sigma, clone B512) and anti-Vinculin (Santa Cruz, sc-7649).
Primary Neuron Culture
Embryonic day 17 (E17) hippocampal neurons were isolated from embryos of
timed pregnant Sprague-Dawley rats (Charles River Laboratories) as previ-
ously described (Goetze et al., 2006). Dissociated primary cortical neurons
were prepared from cortices remaining from hippocampal dissections. See
Supplemental Experimental Procedures for more information.
Lentivirus Production
For lentivirus production, HEK293-FT were transiently cotransfected
with psPAX2, pVSVg, and the shRNA constructs using Lipofectamine
2000 (Invitrogen). Supernatants were concentrated by ultracentrifugation
(22,000 rpm, 2 hr, SW28 rotor; Beckman Coulter). Virus particles were resus-
pended in Neurobasal medium (Life Technologies). Neurons were transduced
on day 2 and collected on day 5 for analysis (DIV 2+5).
Computational Analysis of Staufen Target 30 UTRs
WedownloadedRattus norvegicus (Rnor_5.0) cDNA sequences from Ensembl
using BioMart in August 2013 and defined 30 UTRs as the portion of the cDNA
30- to the open reading frame, as defined by Ensembl. When there were
multiple isoforms for a gene, we used the longest isoform to represent its
mature mRNA sequence. Then, to identify SRSs in these 30 UTRs, we followed
our previously described protocol (Laver et al., 2013). See Supplemental
Experimental Procedures for details.
Luciferase Assay
Gene fragments of interest were cloned downstream of the Renilla luciferase
gene into the psiCHECK-2 vector (Promega). As control, empty luciferase
reporter plasmidwas used. Rat primary cortical neurons (E17–E18) were trans-
fected with 5 mg of reporter plasmid and 25 mg of shRNA plasmid into 1.23 106Cell Recells and then distributed into six wells of a 24-well plate. Luciferase assays
were performed after 3 days using the Dual-Luciferase Reporter Assay System
(Promega) according to the manufacturer’s instructions using the GloMax
device (Promega). Ratios of Renilla/Firefly luciferase activity were calculated
and normalized to the shControl and the luciferase empty vector. The mean
of the normalized ratio from three or more independent experiments was
used to determine significant differences with the Student’s t test.
Further details are available in Supplemental Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures,
four figures, and six tables and can be found with this article online at http://
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